Testing the cognitive effects of tadalafil. Neuropsychological secondary outcomes from the PASTIS trial
Authors:
Open Access
- 26 September 2023
- journal article
- research article
- Published by Elsevier in Cerebral Circulation - Cognition and Behavior
- Vol. 5, 100187
Abstract
No abstract availableKeywords
Funding Information
- NIHR (CL-2015–16–001)
- Alzheimer's Society
- Alzheimer's Drug Discovery Foundation (20140901)
This publication has 42 references indexed in Scilit:
- Tadalafil crosses the blood–brain barrier and reverses cognitive dysfunction in a mouse model of ADNeuropharmacology, 2013
- Phosphodiesterases as Therapeutic Targets for Alzheimer's DiseaseACS Chemical Neuroscience, 2012
- Selective phosphodiesterase inhibitors improve performance on the ED/ID cognitive task in ratsNeuropharmacology, 2012
- Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's diseaseBritish Journal of Pharmacology, 2011
- Effects of repeated dosing with Udenafil (Zydena) on cognition, somatization and erection in patients with erectile dysfunction: a pilot studyInternational Journal Of Impotence Research, 2011
- Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissuesNeuropharmacology, 2010
- Phosphodiesterase Inhibitors Enhance Object Memory Independent of Cerebral Blood Flow and Glucose Utilization in RatsNeuropsychopharmacology, 2009
- A placebo-controlled study of sildenafil effects on cognition in schizophreniaPsychopharmacology, 2008
- Effects of gender, age, diabetes mellitus and renal and hepatic impairment on tadalafil pharmacokineticsBritish Journal of Clinical Pharmacology, 2006
- Tadalafil pharmacokinetics in healthy subjectsBritish Journal of Clinical Pharmacology, 2005